Novozymes A/S (OTCMKTS:NVZMY) Hits New 1-Year Low – Time to Sell?

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as $52.11 and last traded at $54.1240, with a volume of 905 shares. The stock had previously closed at $55.00.

Novozymes A/S Trading Down 2.0%

The firm’s 50 day moving average price is $60.83 and its 200-day moving average price is $61.86. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.61 and a quick ratio of 1.00. The stock has a market cap of $22.35 billion, a P/E ratio of 38.51, a P/E/G ratio of 0.99 and a beta of 1.11.

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.44). The firm had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Novozymes A/S had a return on equity of 6.38% and a net margin of 13.96%. As a group, equities research analysts forecast that Novozymes A/S will post 1.82 earnings per share for the current year.

About Novozymes A/S

(Get Free Report)

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

See Also

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.